Apollon Wealth Management »

Compass Therapeutics shares owned by Apollon Wealth Management

Quarter-by-quarter ownership of Compass Therapeutics (CMPX) shares owned by Apollon Wealth Management from 13F filings

Historical chart of Apollon Wealth Management investment in Compass Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Compass Therapeutics held by Apollon Wealth Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Compass Therapeutics by Apollon Wealth Management

Quarter filed Position value Share count Share price at filing
2025-09-30 $35k 10k 3.50

More positions owned by Apollon Wealth Management

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Vanguard Scottsdale Fds Vng Rus1000grw (VONG)
Amazon (AMZN)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Broadcom (AVGO)
Alphabet Cap Stk Cl A (GOOGL)
Pgim Etf Tr Total Return Bon (PTRB)
Meta Platforms Cl A (META)
JPMorgan Chase & Co. (JPM)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Hartford Fds Exchange Traded Core Bd Etf (HCRB)

View all positions for Apollon Wealth Management

Top funds holding Compass Therapeutics

Tang Capital Management
OrbiMed Advisors
Suvretta Capital Management
Blackstone Group
Vivo Capital
Enavate Sciences GP
BlackRock
Vanguard Group
Adage Capital Partners GP
MPM Oncology Impact Management
BVF
Rock Springs Capital Management
FMR
Millennium Management
State Street Corporation

View all funds holding Compass Therapeutics